236 related articles for article (PubMed ID: 29495001)
41. Dipeptidyl peptidase-4 inhibitor gemigliptin protects against vascular calcification in an experimental chronic kidney disease and vascular smooth muscle cells.
Choi SY; Ryu HM; Oh EJ; Choi JY; Cho JH; Kim CD; Kim YL; Park SH
PLoS One; 2017; 12(7):e0180393. PubMed ID: 28686724
[TBL] [Abstract][Full Text] [Related]
42. TLR2 Promotes Vascular Smooth Muscle Cell Chondrogenic Differentiation and Consequent Calcification via the Concerted Actions of Osteoprotegerin Suppression and IL-6-Mediated RANKL Induction.
Lee GL; Yeh CC; Wu JY; Lin HC; Wang YF; Kuo YY; Hsieh YT; Hsu YJ; Kuo CC
Arterioscler Thromb Vasc Biol; 2019 Mar; 39(3):432-445. PubMed ID: 30626205
[TBL] [Abstract][Full Text] [Related]
43. p38 MAPK activation is required for esculetin-induced inhibition of vascular smooth muscle cells proliferation.
Yun ES; Park SS; Shin HC; Choi YH; Kim WJ; Moon SK
Toxicol In Vitro; 2011 Oct; 25(7):1335-42. PubMed ID: 21600278
[TBL] [Abstract][Full Text] [Related]
44. Rat aortic smooth muscle cell density affects activation of MAP kinase and Akt by menadione and PDGF homodimer BB.
Li XA; Bianchi C; Sellke FW
J Surg Res; 2001 Oct; 100(2):197-204. PubMed ID: 11592793
[TBL] [Abstract][Full Text] [Related]
45. Msx2 is required for vascular smooth muscle cells osteoblastic differentiation but not calcification in insulin-resistant ob/ob mice.
Andrade MC; Carmo LS; Farias-Silva E; Liberman M
Atherosclerosis; 2017 Oct; 265():14-21. PubMed ID: 28829997
[TBL] [Abstract][Full Text] [Related]
46. Deletion of IκB-Kinase β in Smooth Muscle Cells Induces Vascular Calcification Through β-Catenin-Runt-Related Transcription Factor 2 Signaling.
Al-Huseini I; Ashida N; Kimura T
J Am Heart Assoc; 2018 Jan; 7(1):. PubMed ID: 29301759
[TBL] [Abstract][Full Text] [Related]
47. Reduction of inorganic phosphate-induced human smooth muscle cells calcification by inhibition of protein kinase A and p38 mitogen-activated protein kinase.
Kang JH; Toita R; Asai D; Yamaoka T; Murata M
Heart Vessels; 2014 Sep; 29(5):718-22. PubMed ID: 24141990
[TBL] [Abstract][Full Text] [Related]
48. Honokiol causes the p21WAF1-mediated G(1)-phase arrest of the cell cycle through inducing p38 mitogen activated protein kinase in vascular smooth muscle cells.
Lee B; Kim CH; Moon SK
FEBS Lett; 2006 Oct; 580(22):5177-84. PubMed ID: 16962592
[TBL] [Abstract][Full Text] [Related]
49. Possible Mechanisms of Di(2-ethylhexyl) Phthalate-Induced MMP-2 and MMP-9 Expression in A7r5 Rat Vascular Smooth Muscle Cells.
Shih MF; Pan KH; Cherng JY
Int J Mol Sci; 2015 Dec; 16(12):28800-11. PubMed ID: 26690114
[TBL] [Abstract][Full Text] [Related]
50. Vitamin K2 inhibits rat vascular smooth muscle cell calcification by restoring the Gas6/Axl/Akt anti-apoptotic pathway.
Qiu C; Zheng H; Tao H; Yu W; Jiang X; Li A; Jin H; Lv A; Li H
Mol Cell Biochem; 2017 Sep; 433(1-2):149-159. PubMed ID: 28386842
[TBL] [Abstract][Full Text] [Related]
51. cAMP-response element-binding protein mediates tumor necrosis factor-alpha-induced vascular smooth muscle cell migration.
Ono H; Ichiki T; Fukuyama K; Iino N; Masuda S; Egashira K; Takeshita A
Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1634-9. PubMed ID: 15242860
[TBL] [Abstract][Full Text] [Related]
52. Vitamin K2 can suppress the expression of Toll-like receptor 2 (TLR2) and TLR4, and inhibit calcification of aortic intima in ApoE
Wang Z; Wang Z; Zhu J; Long X; Yan J
Vascular; 2018 Feb; 26(1):18-26. PubMed ID: 28587577
[TBL] [Abstract][Full Text] [Related]
53. PINK1/Parkin-mediated mitophagy promotes apelin-13-induced vascular smooth muscle cell proliferation by AMPKα and exacerbates atherosclerotic lesions.
He L; Zhou Q; Huang Z; Xu J; Zhou H; Lv D; Lu L; Huang S; Tang M; Zhong J; Chen JX; Luo X; Li L; Chen L
J Cell Physiol; 2019 Jun; 234(6):8668-8682. PubMed ID: 30456860
[TBL] [Abstract][Full Text] [Related]
54. MicroRNA-204 regulates vascular smooth muscle cell calcification in vitro and in vivo.
Cui RR; Li SJ; Liu LJ; Yi L; Liang QH; Zhu X; Liu GY; Liu Y; Wu SS; Liao XB; Yuan LQ; Mao DA; Liao EY
Cardiovasc Res; 2012 Nov; 96(2):320-9. PubMed ID: 22871591
[TBL] [Abstract][Full Text] [Related]
55. Angiotensin II-induced Akt activation through the epidermal growth factor receptor in vascular smooth muscle cells is mediated by phospholipid metabolites derived by activation of phospholipase D.
Li F; Malik KU
J Pharmacol Exp Ther; 2005 Mar; 312(3):1043-54. PubMed ID: 15525798
[TBL] [Abstract][Full Text] [Related]
56. Upregulation of RGS4 expression by IL-1beta in colonic smooth muscle is enhanced by ERK1/2 and p38 MAPK and inhibited by the PI3K/Akt/GSK3beta pathway.
Hu W; Li F; Mahavadi S; Murthy KS
Am J Physiol Cell Physiol; 2009 Jun; 296(6):C1310-20. PubMed ID: 19369446
[TBL] [Abstract][Full Text] [Related]
57. Reconstituted HDL-apoE3 promotes endothelial cell migration through ID1 and its downstream kinases ERK1/2, AKT and p38 MAPK.
Valanti EK; Dalakoura-Karagkouni K; Fotakis P; Vafiadaki E; Mantzoros CS; Chroni A; Zannis V; Kardassis D; Sanoudou D
Metabolism; 2022 Feb; 127():154954. PubMed ID: 34875308
[TBL] [Abstract][Full Text] [Related]
58. Functional cooperation between vitamin D receptor and Runx2 in vitamin D-induced vascular calcification.
Han MS; Che X; Cho GH; Park HR; Lim KE; Park NR; Jin JS; Jung YK; Jeong JH; Lee IK; Kato S; Choi JY
PLoS One; 2013; 8(12):e83584. PubMed ID: 24349534
[TBL] [Abstract][Full Text] [Related]
59. Metformin protects against vascular calcification through the selective degradation of Runx2 by the p62 autophagy receptor.
Phadwal K; Koo E; Jones RA; Forsythe RO; Tang K; Tang Q; Corcoran BM; Caporali A; MacRae VE
J Cell Physiol; 2022 Nov; 237(11):4303-4316. PubMed ID: 36166694
[TBL] [Abstract][Full Text] [Related]
60. The lignan (+)-episesamin interferes with TNF-α-induced activation of VSMC via diminished activation of NF-ĸB, ERK1/2 and AKT and decreased activity of gelatinases.
Freise C; Querfeld U
Acta Physiol (Oxf); 2015 Mar; 213(3):642-52. PubMed ID: 25267105
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
